MaxCyte Inc (NAS:MXCT)
$ 4.9 -0.05 (-1.01%) Market Cap: 506.68 Mil Enterprise Value: 367.80 Mil PE Ratio: 0 PB Ratio: 2.23 GF Score: 78/100

Q4 2023 MaxCyte Inc Earnings Call Transcript

Mar 12, 2024 / 08:30PM GMT
Release Date Price: $3.98 (+0.25%)
Operator

Good day, and thank you for standing by, and welcome to the MaxCyte fourth quarter earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your first speaker today, Sean Menarguez, Senior Director of Innovation and Business Development. Please go ahead.

Sean Menarguez
MaxCyte, Inc. - Senior Director of Innovation and Business Development

Well, thank you and good afternoon, everyone. My name is Sean Menarguez, and I'm the Senior Director of Innovation & Business Development here at MAX site. Thank you all for participating in today's conference call. On the call from that site, we have Maher Masoud, President and Chief Executive Officer; and Douglas J. Swirsky, Chief Financial Officer.

Earlier today, Max that released financial results for the fourth quarter and full year ended December 31, 2023. A copy the press release is available on the company's website.

Before we begin, I need to read the following statement Statements or

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot